Journal of Bioactive and Compatible Polymers

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pató, J.
Right arrow Articles by Hudecz, F.
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Bioactive and Compatible Polymers, Vol. 14, No. 2, 99-121 (1999)
DOI: 10.1177/088391159901400201

Synthesis of Macromolecular Conjugates of a Urokinase Inhibitor: Amiloride

Janos Pató

Chemical Institute, Chemical Research Center, Pusztaszeri u. 59-67, 1525 Budapest, Hungary

Karel Ulbrich

Institute of Macromolecular Chemistry, Heyrovsky Sq. 2, 16206 Prague 6, Czech Republic

Vladimir Subr

Institute of Macromolecular Chemistry, Heyrovsky Sq. 2, 16206 Prague 6, Czech Republic

Peter Baker

Department of Surgery, University of Birmingham, B152THBirmingham, UK

Gábor Mezö

Research Group of Peptide Chemistry, Hungarian Academy of Sciences, Eötvös L. University, Pázmány P s. 2, 1518 Budapest, Hungary

Ferenc Hudecz

Research Group of Peptide Chemistry, Hungarian Academy of Sciences, Eötvös L. University, Pázmány P s. 2, 1518 Budapest, Hungary

Amiloride is a potent inhibitor of a urokinase type plasminogen activator which is involved in the invasive process of cancer cells leading to the initiation of metastasis. Synthesis, characterization and in vitro tests of four macromolecular conjugates of Amiloride are presented. One of them is a degradable derivative, HPMA-Gly-D,l-Phe-Leu-Gly-amiloride. In this case the in vitro release of Amiloride was monitored. Other conjugates are stable containing a new amiloride derivative, 6-aminohexyl amiloride [AHA], coupled to different polymeric carriers: a branched polypeptide, poly-[Lys(AcGlu1.0-D,l-Ala4.5)] [AcEAK], poly-[N-(2-hydroxy propyl) metacrylamide] [HPMA] and poly-[1-vinyl-2-pyrrolidone-co-maleic acid] [NVP MA]. Inhibition of uPA, plasminogen activation and proteinases secreted by cancer cells was measured as well as basement membrane degradation in vitro. Each amiloride AHA and the corresponding conjugates retained their activity in these experiments.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?